Health & Biotech
Stories by Nadine McGrath
News
ASX December Winners: Santa didn’t rally but at least these 50 stocks went okay
Health & Biotech
Health Check: Percheron board addresses shareholders after failed phase 2b trial
News
Donald Trump’s second coming brings uncertain outlook for 2025 global markets
Health & Biotech
ASX healthcare 2024 winners and losers, plus what’s next for 2025
Health & Biotech
Stocking stuffers: Morgans’ top ASX health picks for 2025
Health & Biotech
Scott Power: Which stock fell off its perch on poor trial results this week?
News
Experts forecast further growth in private credit market in 2025
Experts
Tru Datt: The ASX resources sector looks strong in 2025 and here are three stocks that show why
Health & Biotech
Scott Power: The lowdown on Sonic’s $700m German excursion
News
Short and Caught: Which uranium play is now the ASX’s most-shorted stock?
Health & Biotech